Neuroone Medical Technologies (NMTC) EPS (Basic) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.55% |
| Dec 31, 2025 | 35.07% |
| Sep 30, 2025 | -17.32% |
| Jun 30, 2025 | 53.16% |
| Mar 31, 2025 | -8.70% |
| Dec 31, 2024 | 16.83% |
| Sep 30, 2024 | -4.10% |
| Jun 30, 2024 | 6.51% |
| Mar 31, 2024 | 11.27% |
| Jun 30, 2023 | -4.56% |
| Mar 31, 2023 | -4.32% |
| Dec 31, 2022 | 12.13% |
| Sep 30, 2022 | 12.94% |
| Jun 30, 2022 | 5.03% |
| Mar 31, 2022 | -6.30% |
| Dec 31, 2021 | -24.57% |
| Sep 30, 2021 | -85.56% |
| Jun 30, 2021 | -160.41% |
| Mar 31, 2021 | -205.32% |
| Dec 31, 2020 | -91.86% |
| Sep 30, 2020 | 162.28% |
| Jun 30, 2020 | -353.43% |
| Mar 31, 2020 | -163.49% |
| Jun 30, 2019 | -113.48% |
| Mar 31, 2019 | -199.25% |
| Jun 30, 2018 | -106.61% |
| Mar 31, 2018 | -204.25% |
| Dec 31, 2017 | -275.61% |
| Sep 30, 2017 | -179.13% |
| Jun 30, 2017 | -234.87% |
| Mar 31, 2017 | -163.66% |
| Dec 31, 2016 | -43.10% |
| Sep 30, 2016 | -61.11% |
| Jun 30, 2016 | -50.42% |
| Mar 31, 2016 | 11.85% |
| Dec 31, 2015 | -139.29% |
| Sep 30, 2015 | -3.67% |